Modification of 5-fluorouracil activity by high-dose methotrexate or leucovorin in advanced colorectal carcinoma
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (5) , 625-628
- https://doi.org/10.1016/0277-5379(90)90094-a
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.Journal of Clinical Oncology, 1989
- Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimensEuropean Journal of Cancer and Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Continuous low-dose infusion of fluorouracil: is the benefit worth the cost?Journal of Clinical Oncology, 1989
- New vistas for leucovorin in cancer chemotherapyCancer, 1989
- Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthaseCancer, 1989
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Sequential methotrexate-5-FU-leucovorin (MFL) in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1986
- Survival and response to chemotherapy for advanced colorectal adenocarcinoma. An eastern cooperative oncology group reportCancer, 1980
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979